Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 2.12M | € 1.48M | € 2.23M | € 3.68M | € 3.28M |
Total Assets | € 1.93B | € 1.81B | € 1.76B | € 1.76B | € 1.76B |
Total Debt | € 865.63M | € 865.71M | € 911.51M | € 894.80M | € 930.75M |
Net Debt | € 863.50M | € 864.23M | € 909.28M | € 891.12M | € 927.47M |
Total Liabilities | € 907.23M | € 891.25M | € 962.43M | € 954.78M | € 994.46M |
Stockholders Equity | € 1.02B | € 920.98M | € 795.94M | € 808.22M | € 770.43M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |